ObjectiveTo summarize the progress of radiomics in the diagnosis and treatment of hepatocellular carcinoma and discuss its future direction, limitations and challenges. MethodWe retrieve the literature related to radiomics in the diagnosis and treatment of hepatocellular carcinoma and make an review. ResultsTraditional hepatocellular carcinoma imaging examination, diagnosis and differential diagnosis had certain limitations. Radiomics as an emerging technology, it helped extract tissue biological information that could not be detected by the naked eye from high-throughput quantitative images and transform into high-dimensional qualitative quantitative data, and either alone or in combination with other clinical and molecular data such as demographics, histology, genomics or proteomics or other clinical and molecular data to solve clinical problems such as hepatocellular carcinoma diagnosis and differential diagnosis, staging and grading, therapeutic regimen development and predicting prognosis and survival after therapy, etc. At present, there were still several problems to be solved in radiomics, such as insufficient interpretability of the combined artificial intelligence-medical imaging approach, lack of uniform standards and lack of external validation, etc. ConclusionsThe study of radiomics in the diagnosis and treatment of hepatocellular carcinoma has been deepened and expanded to different degrees with great potential and application prospects. Radiomics brings greater benefits to the diagnosis, treatment and management of hepatocellular carcinoma patients, provides a new direction for optimizing medical decision-making and promoting the development of precision medicine. However, there are still some deficiencies and challenges to overcome in the radiomics technology and methods, which require extensive validation and optimization through further clinical trials.